<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00678379</url>
  </required_header>
  <id_info>
    <org_study_id>080127</org_study_id>
    <nct_id>NCT00678379</nct_id>
  </id_info>
  <brief_title>Pediatric Tonsillectomy Pain Reduction Study</brief_title>
  <official_title>Pediatric Tonsillectomy Pain Reduction Study, a Randomized, Placebo Controlled, Double-Blind Clinical Trial Using Clonidine and Local Anesthetics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tonsillectomy is associated with a significant decrease quality of life in children secondary
      to pain, which is worsened with swallowing. The objective of the current study is to conduct
      a prospective, double-blind, placebo-controlled, randomized clinical trial using a
      pre-tonsillectomy infiltration of the tonsillar fossa comparing three treatment regimens in
      reducing post-tonsillectomy morbidity (i.e. pain, poor oral intake): 1) Placebo (saline
      injection) 2) bupivacaine (0.5%) + lidocaine (1%), 3) bupivacaine (0.5%) + lidocaine (1%) +
      clonidine (25 µg).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Tonsillectomy is associated with a significant decrease quality of life in children secondary
      to pain, which is worsened with swallowing. Previous studies in the pediatric population have
      demonstrated a significant decrease in post-operative pain/morbidity when administering pain
      reduction medications into the tonsillar fossa prior to removal. While these studies have
      shown great promise, no large randomized trial of the most promising medications has been
      conducted. Because of this, many otolaryngologists do not administer intra-operative
      medications aimed at reducing post-operative pain. The objective of the current study is to
      conduct a prospective, double-blind, placebo-controlled, randomized clinical trial using a
      pre-tonsillectomy infiltration of the tonsillar fossa comparing three treatment regimens in
      reducing post-tonsillectomy morbidity (i.e. pain, poor oral intake): 1) Placebo (saline
      injection) 2) bupivacaine (0.5%) + lidocaine (1%), 3) bupivacaine (0.5%) + lidocaine (1%) +
      clonidine (25 µg).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Number of Post-operative Doses of Analgesics.</measure>
    <time_frame>Post-operative thru day 7</time_frame>
    <description>The total number of intravenous fentanyl doses given PACU which will be compared between the three randomized groups (arms)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Median Number of Pain Medication Doses</measure>
    <time_frame>in recovery room</time_frame>
    <description>The median number of intravenous fentanyl doses administered in the PACU due to pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Time Until Discharge From Hospital.</measure>
    <time_frame>Day of Surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Visual Analog Scale Pain Number.</measure>
    <time_frame>in recovery room; post-operative days 1,3,5 &amp; 7</time_frame>
    <description>Visual analog pain scale range is 0-10 with 0=no pain and 10 = worst pain ever</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and Percent of Participants Able to Tolerate Only Liquids</measure>
    <time_frame>post-operative days 1,3,5 &amp; 7.</time_frame>
    <description>The number and percent of patients whose post-operative diet has advanced to liquids only on post-op days 1, 3, 5 &amp; 7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and Percent of Participants Able to Tolerate Only a Soft Diet</measure>
    <time_frame>post-operative days 1,3,5 &amp; 7.</time_frame>
    <description>The number and percent of patients whose post-operative diet has only advanced to a soft diet on post-operative days 1, 3, 5 &amp; 7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and Percent of Participants Able to Tolerate a Regular Diet</measure>
    <time_frame>post-operative days 1,3,5 &amp; 7.</time_frame>
    <description>The number and percent of patients whose post-operative diet has to a regular diet on post-operative days 1, 3, 5 &amp; 7</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Normal Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1.5 ml injection of Normal Saline into each tonsillar fossa pre-tonsillectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine (1%) + Bupivacaine 0.5%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Submucosal injection of 1.5 mL Lidocaine (1%) + Bupivacaine 0.5% into the tonsillar fossa, pre-tonsillectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine + Bupivacaine + Clondine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Submucosal injection of 1.5 mL Lidocaine 1% + Bupivacaine 0.5% + Clondine 25mcg into the tonsillar fossa, pre-tonsillectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lidocaine (1%) + bupivacaine (0.5%)</intervention_name>
    <description>Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy.
B - lidocaine (1%) + bupivacaine (0.5%)</description>
    <arm_group_label>Lidocaine (1%) + Bupivacaine 0.5%</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy.
A - normal saline</description>
    <arm_group_label>Normal Saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine (1%) + Bupivacaine (0.5%) + Clonidine (25mcg)</intervention_name>
    <description>Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy.
C - lidocaine (1%) + bupivacaine (0.5%) + clonidine (25mcg)</description>
    <arm_group_label>Lidocaine + Bupivacaine + Clondine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 3 - 17 years old

          -  BMI &lt; 35

          -  Negative pregnancy test in female patients age 10 and older

          -  Diagnosed with adenotonsillar hypertrophy, recurrent adenotonsillitis or upper airway
             obstruction and will be undergoing tonsillectomy alone or adenotonsillectomy

        Exclusion Criteria:

          -  Diagnosis of obstructive sleep apnea

          -  Patient with peritonsillar abscess

          -  Allergy to study medication

          -  Any major systemic illness, genetic disorder or diagnosed syndrome

          -  Bleeding disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonathan R Moss, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University Monroe Carrel Jr. Children's Hospital</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37299</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Cucchiaro G, Ganesh A. The effects of clonidine on postoperative analgesia after peripheral nerve blockade in children. Anesth Analg. 2007 Mar;104(3):532-7.</citation>
    <PMID>17312203</PMID>
  </reference>
  <reference>
    <citation>Naja MZ, El-Rajab M, Kabalan W, Ziade MF, Al-Tannir MA. Pre-incisional infiltration for pediatric tonsillectomy: a randomized double-blind clinical trial. Int J Pediatr Otorhinolaryngol. 2005 Oct;69(10):1333-41. Epub 2005 Apr 22.</citation>
    <PMID>16159655</PMID>
  </reference>
  <reference>
    <citation>McCartney CJ, Duggan E, Apatu E. Should we add clonidine to local anesthetic for peripheral nerve blockade? A qualitative systematic review of the literature. Reg Anesth Pain Med. 2007 Jul-Aug;32(4):330-8. Review.</citation>
    <PMID>17720118</PMID>
  </reference>
  <reference>
    <citation>Jebeles JA, Reilly JS, Gutierrez JF, Bradley EL Jr, Kissin I. Tonsillectomy and adenoidectomy pain reduction by local bupivacaine infiltration in children. Int J Pediatr Otorhinolaryngol. 1993 Jan;25(1-3):149-54.</citation>
    <PMID>8436459</PMID>
  </reference>
  <reference>
    <citation>Jebeles JA, Reilly JS, Gutierrez JF, Bradley EL Jr, Kissin I. The effect of pre-incisional infiltration of tonsils with bupivacaine on the pain following tonsillectomy under general anesthesia. Pain. 1991 Dec;47(3):305-8.</citation>
    <PMID>1784501</PMID>
  </reference>
  <reference>
    <citation>Giannoni C, White S, Enneking FK, Morey T. Ropivacaine with or without clonidine improves pediatric tonsillectomy pain. Arch Otolaryngol Head Neck Surg. 2001 Oct;127(10):1265-70.</citation>
    <PMID>11587610</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 8, 2008</study_first_submitted>
  <study_first_submitted_qc>May 14, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 15, 2008</study_first_posted>
  <results_first_submitted>May 1, 2017</results_first_submitted>
  <results_first_submitted_qc>June 5, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">July 2, 2017</results_first_posted>
  <last_update_submitted>June 5, 2017</last_update_submitted>
  <last_update_submitted_qc>June 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Jonathan R. Moss</investigator_full_name>
    <investigator_title>Resident Physician</investigator_title>
  </responsible_party>
  <keyword>Tonsillectomy</keyword>
  <keyword>Postoperative Pain</keyword>
  <keyword>Clonidine</keyword>
  <keyword>Anesthetics, Local</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Clonidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>No plan to share unless specifically requested within 5 year storage of data period.</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Normal Saline</title>
          <description>Normal Saline
normal saline: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
A - normal saline</description>
        </group>
        <group group_id="P2">
          <title>Lidocaine (1%) + Bupivacaine 0.5%</title>
          <description>Lidocaine (1%) + Bupivacaine 0.5%
lidocaine + bupivacaine: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
B - lidocaine (1%) + bupivacaine (0.5%)</description>
        </group>
        <group group_id="P3">
          <title>Lidocaine 1% + Bupivacaine o.5% + Clondine 25mcg</title>
          <description>Lidocaine 1% + Bupivacaine o.5% + Clondine 25mcg
lidocaine + bupivacaine + clonidine: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
C - lidocaine (1%) + bupivacaine (0.5%) + clonidine (25mcg)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
                <participants group_id="P3" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="37"/>
                <participants group_id="P3" count="36"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Injection performed after tonsillectomy</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Incomplete Data</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Normal Saline</title>
          <description>Normal Saline
normal saline: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
A - normal saline</description>
        </group>
        <group group_id="B2">
          <title>Lidocaine (1%) + Bupivacaine 0.5%</title>
          <description>Lidocaine (1%) + Bupivacaine 0.5%
lidocaine + bupivacaine: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
B - lidocaine (1%) + bupivacaine (0.5%)</description>
        </group>
        <group group_id="B3">
          <title>Lidocaine 1% + Bupivacaine o.5% + Clondine 25mcg</title>
          <description>Lidocaine 1% + Bupivacaine o.5% + Clondine 25mcg
lidocaine + bupivacaine + clonidine: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
C - lidocaine (1%) + bupivacaine (0.5%) + clonidine (25mcg)</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="40"/>
            <count group_id="B2" value="40"/>
            <count group_id="B3" value="40"/>
            <count group_id="B4" value="120"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6" lower_limit="5" upper_limit="9"/>
                    <measurement group_id="B2" value="7" lower_limit="5" upper_limit="11"/>
                    <measurement group_id="B3" value="8" lower_limit="5" upper_limit="12"/>
                    <measurement group_id="B4" value="7" lower_limit="5" upper_limit="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="67"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="40"/>
                    <measurement group_id="B4" value="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Total Number of Post-operative Doses of Analgesics.</title>
        <description>The total number of intravenous fentanyl doses given PACU which will be compared between the three randomized groups (arms)</description>
        <time_frame>Post-operative thru day 7</time_frame>
        <population>Number of patients randomized to each group</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline</title>
            <description>Normal Saline
normal saline: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
A - normal saline</description>
          </group>
          <group group_id="O2">
            <title>Lidocaine (1%) + Bupivacaine 0.5%</title>
            <description>Lidocaine (1%) + Bupivacaine 0.5%
lidocaine + bupivacaine: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
B - lidocaine (1%) + bupivacaine (0.5%)</description>
          </group>
          <group group_id="O3">
            <title>Lidocaine 1% + Bupivacaine o.5% + Clondine 25mcg</title>
            <description>Lidocaine 1% + Bupivacaine o.5% + Clondine 25mcg
lidocaine + bupivacaine + clonidine: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
C - lidocaine (1%) + bupivacaine (0.5%) + clonidine (25mcg)</description>
          </group>
        </group_list>
        <measure>
          <title>Total Number of Post-operative Doses of Analgesics.</title>
          <description>The total number of intravenous fentanyl doses given PACU which will be compared between the three randomized groups (arms)</description>
          <population>Number of patients randomized to each group</population>
          <units>number of doses</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" lower_limit="9" upper_limit="15"/>
                    <measurement group_id="O2" value="12" lower_limit="10" upper_limit="16.5"/>
                    <measurement group_id="O3" value="14" lower_limit="9" upper_limit="16.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Median Number of Pain Medication Doses</title>
        <description>The median number of intravenous fentanyl doses administered in the PACU due to pain</description>
        <time_frame>in recovery room</time_frame>
        <population>per group doses</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline</title>
            <description>Normal Saline
normal saline: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
A - normal saline</description>
          </group>
          <group group_id="O2">
            <title>Lidocaine (1%) + Bupivacaine 0.5%</title>
            <description>Lidocaine (1%) + Bupivacaine 0.5%
lidocaine + bupivacaine: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
B - lidocaine (1%) + bupivacaine (0.5%)</description>
          </group>
          <group group_id="O3">
            <title>Lidocaine 1% + Bupivacaine o.5% + Clondine 25mcg</title>
            <description>Lidocaine 1% + Bupivacaine o.5% + Clondine 25mcg
lidocaine + bupivacaine + clonidine: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
C - lidocaine (1%) + bupivacaine (0.5%) + clonidine (25mcg)</description>
          </group>
        </group_list>
        <measure>
          <title>Median Number of Pain Medication Doses</title>
          <description>The median number of intravenous fentanyl doses administered in the PACU due to pain</description>
          <population>per group doses</population>
          <units>number of doses</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0" lower_limit="3.0" upper_limit="5.0"/>
                    <measurement group_id="O2" value="3" lower_limit="2" upper_limit="4"/>
                    <measurement group_id="O3" value="3" lower_limit="2" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Time Until Discharge From Hospital.</title>
        <time_frame>Day of Surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline</title>
            <description>Normal Saline
normal saline: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
A - normal saline</description>
          </group>
          <group group_id="O2">
            <title>Lidocaine (1%) + Bupivacaine 0.5%</title>
            <description>Lidocaine (1%) + Bupivacaine 0.5%
lidocaine + bupivacaine: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
B - lidocaine (1%) + bupivacaine (0.5%)</description>
          </group>
          <group group_id="O3">
            <title>Lidocaine 1% + Bupivacaine o.5% + Clondine 25mcg</title>
            <description>Lidocaine 1% + Bupivacaine o.5% + Clondine 25mcg
lidocaine + bupivacaine + clonidine: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
C - lidocaine (1%) + bupivacaine (0.5%) + clonidine (25mcg)</description>
          </group>
        </group_list>
        <measure>
          <title>Total Time Until Discharge From Hospital.</title>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="122" lower_limit="90" upper_limit="188"/>
                    <measurement group_id="O2" value="111" lower_limit="81" upper_limit="142"/>
                    <measurement group_id="O3" value="120" lower_limit="79" upper_limit="175"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Visual Analog Scale Pain Number.</title>
        <description>Visual analog pain scale range is 0-10 with 0=no pain and 10 = worst pain ever</description>
        <time_frame>in recovery room; post-operative days 1,3,5 &amp; 7</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline</title>
            <description>Normal Saline
normal saline: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
A - normal saline</description>
          </group>
          <group group_id="O2">
            <title>Lidocaine (1%) + Bupivacaine 0.5%</title>
            <description>Lidocaine (1%) + Bupivacaine 0.5%
lidocaine + bupivacaine: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
B - lidocaine (1%) + bupivacaine (0.5%)</description>
          </group>
          <group group_id="O3">
            <title>Lidocaine 1% + Bupivacaine o.5% + Clondine 25mcg</title>
            <description>Lidocaine 1% + Bupivacaine o.5% + Clondine 25mcg
lidocaine + bupivacaine + clonidine: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
C - lidocaine (1%) + bupivacaine (0.5%) + clonidine (25mcg)</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Visual Analog Scale Pain Number.</title>
          <description>Visual analog pain scale range is 0-10 with 0=no pain and 10 = worst pain ever</description>
          <units>pain score</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>In recovery room</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="2" upper_limit="4"/>
                    <measurement group_id="O2" value="3" lower_limit="2" upper_limit="4"/>
                    <measurement group_id="O3" value="3" lower_limit="2" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="2" upper_limit="6"/>
                    <measurement group_id="O2" value="4" lower_limit="3" upper_limit="5"/>
                    <measurement group_id="O3" value="5" lower_limit="4" upper_limit="5.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="1" upper_limit="3.5"/>
                    <measurement group_id="O2" value="2.5" lower_limit="2" upper_limit="4"/>
                    <measurement group_id="O3" value="3" lower_limit="2" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="1.5" upper_limit="5"/>
                    <measurement group_id="O2" value="2" lower_limit="1" upper_limit="5"/>
                    <measurement group_id="O3" value="3" lower_limit="2" upper_limit="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5" lower_limit="1" upper_limit="3.2"/>
                    <measurement group_id="O2" value="2" lower_limit="1" upper_limit="5"/>
                    <measurement group_id="O3" value="2" lower_limit="1" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number and Percent of Participants Able to Tolerate Only Liquids</title>
        <description>The number and percent of patients whose post-operative diet has advanced to liquids only on post-op days 1, 3, 5 &amp; 7</description>
        <time_frame>post-operative days 1,3,5 &amp; 7.</time_frame>
        <population>per group data</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline</title>
            <description>Normal Saline
normal saline: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
A - normal saline</description>
          </group>
          <group group_id="O2">
            <title>Lidocaine (1%) + Bupivacaine 0.5%</title>
            <description>Lidocaine (1%) + Bupivacaine 0.5%
lidocaine + bupivacaine: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
B - lidocaine (1%) + bupivacaine (0.5%)</description>
          </group>
          <group group_id="O3">
            <title>Lidocaine 1% + Bupivacaine o.5% + Clondine 25mcg</title>
            <description>Lidocaine 1% + Bupivacaine o.5% + Clondine 25mcg
lidocaine + bupivacaine + clonidine: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
C - lidocaine (1%) + bupivacaine (0.5%) + clonidine (25mcg)</description>
          </group>
        </group_list>
        <measure>
          <title>Number and Percent of Participants Able to Tolerate Only Liquids</title>
          <description>The number and percent of patients whose post-operative diet has advanced to liquids only on post-op days 1, 3, 5 &amp; 7</description>
          <population>per group data</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>post-op day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="33"/>
                    <measurement group_id="O3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post-op day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post op day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post op day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number and Percent of Participants Able to Tolerate Only a Soft Diet</title>
        <description>The number and percent of patients whose post-operative diet has only advanced to a soft diet on post-operative days 1, 3, 5 &amp; 7</description>
        <time_frame>post-operative days 1,3,5 &amp; 7.</time_frame>
        <population>per group diet</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline</title>
            <description>Normal Saline
normal saline: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
A - normal saline</description>
          </group>
          <group group_id="O2">
            <title>Lidocaine (1%) + Bupivacaine 0.5%</title>
            <description>Lidocaine (1%) + Bupivacaine 0.5%
lidocaine + bupivacaine: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
B - lidocaine (1%) + bupivacaine (0.5%)</description>
          </group>
          <group group_id="O3">
            <title>Lidocaine 1% + Bupivacaine o.5% + Clondine 25mcg</title>
            <description>Lidocaine 1% + Bupivacaine o.5% + Clondine 25mcg
lidocaine + bupivacaine + clonidine: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
C - lidocaine (1%) + bupivacaine (0.5%) + clonidine (25mcg)</description>
          </group>
        </group_list>
        <measure>
          <title>Number and Percent of Participants Able to Tolerate Only a Soft Diet</title>
          <description>The number and percent of patients whose post-operative diet has only advanced to a soft diet on post-operative days 1, 3, 5 &amp; 7</description>
          <population>per group diet</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>post-op day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="22"/>
                    <measurement group_id="O3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post-op day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post op day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post op day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number and Percent of Participants Able to Tolerate a Regular Diet</title>
        <description>The number and percent of patients whose post-operative diet has to a regular diet on post-operative days 1, 3, 5 &amp; 7</description>
        <time_frame>post-operative days 1,3,5 &amp; 7.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline</title>
            <description>Normal Saline
normal saline: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
A - normal saline</description>
          </group>
          <group group_id="O2">
            <title>Lidocaine (1%) + Bupivacaine 0.5%</title>
            <description>Lidocaine (1%) + Bupivacaine 0.5%
lidocaine + bupivacaine: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
B - lidocaine (1%) + bupivacaine (0.5%)</description>
          </group>
          <group group_id="O3">
            <title>Lidocaine 1% + Bupivacaine o.5% + Clondine 25mcg</title>
            <description>Lidocaine 1% + Bupivacaine o.5% + Clondine 25mcg
lidocaine + bupivacaine + clonidine: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
C - lidocaine (1%) + bupivacaine (0.5%) + clonidine (25mcg)</description>
          </group>
        </group_list>
        <measure>
          <title>Number and Percent of Participants Able to Tolerate a Regular Diet</title>
          <description>The number and percent of patients whose post-operative diet has to a regular diet on post-operative days 1, 3, 5 &amp; 7</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>post-op day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post-op day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post op day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post op day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Each patient was followed for adverse events for the duration they were in the study and up to their post-operative visit at 3 weeks post-surgery.</time_frame>
      <desc>We used the same definition.</desc>
      <group_list>
        <group group_id="E1">
          <title>Normal Saline</title>
          <description>Normal Saline
normal saline: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
A - normal saline</description>
        </group>
        <group group_id="E2">
          <title>Lidocaine (1%) + Bupivacaine 0.5%</title>
          <description>Lidocaine (1%) + Bupivacaine 0.5%
lidocaine + bupivacaine: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
B - lidocaine (1%) + bupivacaine (0.5%)</description>
        </group>
        <group group_id="E3">
          <title>Lidocaine 1% + Bupivacaine o.5% + Clondine 25mcg</title>
          <description>Lidocaine 1% + Bupivacaine o.5% + Clondine 25mcg
lidocaine + bupivacaine + clonidine: Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
C - lidocaine (1%) + bupivacaine (0.5%) + clonidine (25mcg)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="40"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Bleeding</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="40"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="40"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Emergency Department admission</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Severe pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Lingual nerve palsy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jonathan Moss MD</name_or_title>
      <organization>Charlotte Eye Ear Nose and Throat</organization>
      <phone>704-295-3000</phone>
      <email>jmoss@ceenta.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

